Muscle Fiber Type-Predominant Promoter Activity in Lentiviral-Mediated Transgenic Mouse

Dystrophin Delivery to Muscles of mdx Mice Using Lentiviral Vectors Leads to Myogenic Progenitor Targeting and Stable Gene Expression

(2009) En Kimura et al.   MOLECULAR THERAPY

Construction and analysis of compact muscle-specific promoters for AAV vectors

(2008) B Wang et al.   GENE THERAPY

Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy

(2008) E. Kimura et al.   HUMAN MOLECULAR GENETICS

Transduction of Full-length Dystrophin to Multiple Skeletal Muscles Improves Motor Performance and Life Span in Utrophin/Dystrophin Double Knockout Mice

(2008) Ryoko Kawano et al.   MOLECULAR THERAPY

Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2/8 Gene Transfer

(2008) Helen Foster et al.   MOLECULAR THERAPY

Mdx respiratory impairment following fibrosis of the diaphragm

(2008) Masatoshi Ishizaki et al.   NEUROMUSCULAR DISORDERS

Regions downstream from the WW domain of dystrophin are important for binding to postsynaptic densities in the brain

(2008) Tetsuro Sakamoto et al.   NEUROMUSCULAR DISORDERS

Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter

(2008) Kiyohiko Takayama et al.   NEUROSCIENCE LETTERS

Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotyping

(2007) Paul Gregorevic et al.   MUSCLE & NERVE